☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
belzutifan
Merck's Welireg (belzutifan) Receives the US FDA's Approval for the Treatment of Von Hippel-Lindau Disease Associated Tumors
August 16, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.